GILD Form 144: Johanna Mercier Reports 28,000-Share Sale via Morgan Stanley
Rhea-AI Filing Summary
Gilead Sciences insider notice for proposed Rule 144 sale. The filing reports a proposed sale of 28,000 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $3,318,924.65 and the company’s outstanding shares listed as 1,240,806,916. The filer shows recent acquisitions including a 25,000-share stock option exercise dated 08/15/2025, 2,394 performance shares (01/31/2024) and 606 restricted shares (12/10/2023). The form also lists multiple dispositions by Johanna Mercier in the past three months, with individual sales and gross proceeds disclosed for each trade.
Positive
- Clear Rule 144 disclosure: filing specifies broker, share count and aggregate market value for the proposed sale
- Detailed acquisition history: includes dates and types (stock option exercise, performance shares, restricted stock)
- Recent sales documented: multiple dispositions in the past three months with gross proceeds listed
Negative
- Insider liquidity event: proposed sale equals $3.32 million, which may be viewed negatively by some investors
- Multiple recent disposals: repeated sales by the same holder over the past three months could raise investor scrutiny
Insights
TL;DR: Insider has filed to sell a meaningful block of shares, disclosed recent grants and multiple recent sales.
The notice transparently discloses a proposed sale of 28,000 shares valued at $3.32 million via Morgan Stanley Smith Barney and enumerates recent acquisitions including a same-day stock option exercise of 25,000 shares. For investors, this is a routine Rule 144 disclosure showing an insider liquidity event and prior incremental dispositions over the past three months. The filing contains concrete quantities, dates and gross proceeds for recent sales, enabling verification of insider selling activity without offering commentary on motives.
TL;DR: Filing meets Rule 144 disclosure requirements; shows ongoing insider sales and recent equity grants.
The document fulfills required disclosures by identifying the broker, share counts, acquisition methods and recent sales by the holder. Notably, the filer recorded recent equity compensation events (performance shares and restricted stock) along with a sizable option exercise. From a governance perspective, the record of multiple disposals in the prior three months plus a new proposed sale warrants attention to insider selling patterns, but the filing itself is procedural and does not indicate noncompliance.